Automated Insulin Delivery Systems MARKET SWOT ANALYSIS AND SURGE FROM 2020-2027

About This Presentation

Automated Insulin Delivery Systems MARKET SWOT ANALYSIS AND SURGE FROM 2020-2027


This research report categorizes the global Automated Insulin Delivery Systems market by top players/brands, region, type and end user – PowerPoint PPT presentation

Number of Views:21


Transcript and Presenter's Notes

Title: Automated Insulin Delivery Systems MARKET SWOT ANALYSIS AND SURGE FROM 2020-2027

Automated Insulin Delivery Systems Market To
Reach USD 7.81 Billion By 2027
Market Summary
Rise in the global burden of diabetes, increasing
geriatric population, growing rate of obesity,
favorable reimbursement policies, increasing
strategic initiatives such as product launches or
collaborations, and favorable investment
scenarios are among the key factors contributing
to a high CAGR of the Automated Insulin Delivery
Systems market during the forecast
period. Market Size USD 4.91 Billion in 2019,
Market Growth - CAGR of 6.0, Market Trends
Technological advancements and rising demand for
user friendly point of care insulin delivery
Our Approach
Market Summary
  • According to the current analysis of Reports and
    Data, the global Automated Insulin Delivery
    Systems Market was valued at USD 4.91 billion in
    2019 and is expected to reach USD 7.81 billion by
    the year 2027 at a CAGR of 6.0. The Automated
    Insulin Delivery Systems (AID) market is majorly
    driven due to the increasing prevalence of
    diabetes across the globe. Diabetes is a chronic
    metabolic disease characterized by increased
    blood glucose levels or blood sugar, which is
    likely to lead to heart disorders, damage to
    blood vessels, eyes, kidneys, and nerves. In
    2019, nearly 463 million adults from 20 to 79
    years old had diabetes and is estimated to rise
    to about 700 million by 2045 globally, according
    to the International Diabetes Federation.
  • The continuous growth in the target population
    has promoted a rise in technological advances in
    the field emerging tremendous future opportunity
    for Automated Insulin Delivery Systems. For
    instance, one of the leading players in the
    industry Bigfoot Biomedical is engaged in
    developing its advanced AID system Autonomy with
    the use of a screenless pump, a smartphone app,
    and the FreeStyle Libre CGM which is estimated
    to be launched by 2023. Increasing technological
    developments, favorable reimbursement policies,
    and increasing awareness programs are estimated
    to support the market growth. Furthermore, rising
    diabetic population worldwide has attracted
    research investments from private and public
    organizations, towards diabetes management. For
    instance, the NIH has invested in collaboration
    with four institution to support development of
    closed-loop insulin delivery technology or
    Automated Insulin Delivery Systems for pregnant
    women with type 1 diabetes in 2019.
  • To Get Sample Copy of Report visit

Our Approach
Market Summary
  • Key participants include Novo Nordisk A/S,
    Sanofi, Eli Lilly and Company, Biocon, Ypsomed,
    Wockhardt, Digital Medics, Abbott, Companion
    Medical, F. Hoffmann-La Roche, Ltd., BD, Animas
    LLC, Medtronic., Tandem Diabetes Care, Inc,
    Diabetes Care, BIGFOOT BIOMEDICAL, INC, DreaMed
    Diabetes, Ltd and WTWH Media LLC
  • Segments covered in the report
  • Applications Outlook (Revenue in Million USD
  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus
  • End Use outlook (Revenue in Million USD
  • Homecare
  • Hospitals
  • Clinics
  • Others
  • To get a Discount on the Automated Insulin
    Delivery Systems Market Report, Click _at_

Our Approach
Market Summary
  • Product Type Outlook (Revenue in Million USD
  • Devices
  • A) Pens
  • a)Reusable Insulin Pens
  • b)Disposable Insulin Pens
  • B) Insulin Pumps
  • a)External/ Tethered Pumps
  • b)Patch Pumps
  • c)Implanted Insulin pump (IIP)
  • d)Closed loop insulin pump (artificial
  • C) Pen Needles
  • a)Standard Pen Needles
  • b)Safety Pen Needles
  • D) Insulin Syringes
  • E) CGM
  • Software Mobile App
  • Others

Our Approach
Market Summary
  • Further key findings from the report suggest
  • To capture significant clientele, companies are
    engaged in developing advanced automated products
    with enhanced efficiency and ease of use. For
    instance, in June 2020, Medtronic received the
    CE-Mark for its MiniMed 780G. The device
    automatically adjust basal insulin rates after
    every five minutes and is suitable for diabetic
    of 7- 80 year old
  • Expansion of application range of products to
    address larger set of customers is another
    strategic initiative to enhance the business
    target which is likely to promote sales of AID
    products. For instance, in October 2019, Novo
    Nordisk received the U.S. Food and Drug
    Administration (FDA) approval for the expanded
    application of its Fiasp as insulin infusion
    pumps in adults with type 1 or type 2 diabetes as
    an improvement of glycemic control
  • Rising diabetic population globally, many
    companies are investing to develop advanced
    technology. For instance, in February 2020,
    Becton, Dickinson and Company completed a
    clinical trial of its BD Libertas a wearable
  • Emerging technologies in medical device sector
    has been playing great role in rising the growth
    of AID. For instance, in March 2019, Abbott
    Laboratoriesand Novo Nordisk entered into
    non-exclusive partnership that will incorporate
    insulin dose data from Novo Nordisk pre-filled
    and durable connected pens directly into the
    digital health tools compatible with the
    FreeStyle Libre system
  • Read More _at_ https//

Our Approach
About Us
  • Reports and Data is a market research and
    consulting company that provides syndicated
    research reports, customized research reports,
    and consulting services. Our solutions purely
    focus on your purpose to locate, target and
    analyze consumer behavior shifts across
    demographics, across industries and help clients
    make a smarter business decision. We offer market
    intelligence studies ensuring relevant and
    fact-based research across a multiple industries
    including Healthcare, Technology, Chemicals,
    Power, and Energy. We consistently update our
    research offerings to ensure our clients are
    aware about the latest trends existent in the
    market. Reports and Data has a strong base of
    experienced analysts from varied areas of
  • Contact Us
  • John Watson
  • Head of Business Development
  • Reports And Data Web
  • Direct Line 1-212-710-1370
  • E-mail
Write a Comment
User Comments (0)